# The BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR)

Study · id `cardio:ct-nct02521181` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02521181](<https://clinicaltrials.gov/study/NCT02521181>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02521181

Browse, organ or system: Kidneys  
Browse, condition area: Kidney connections  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 194 participants.

## Technical summary

Registry record NCT02521181. Randomized; triple masking; primary purpose other. Start 2015-10 (actual); primary completion 2018-01 (actual). Results posted on 2020-10-20.

## Key facts

- Design: Interventional study; randomized; triple masking; primary purpose other
- Phase: Phase 3
- Enrolled: 194 participants (enrolled count; ClinicalTrials.gov record NCT02521181, source copy `cardio:ctgov-nct02521181-2020-10-20`, retrieved 2026-10-26)
- Started: 2015-10 (actual) (ClinicalTrials.gov record NCT02521181, source copy `cardio:ctgov-nct02521181-2020-10-20`, retrieved 2026-10-26)
- Primary completion: 2018-01 (actual) (ClinicalTrials.gov record NCT02521181, source copy `cardio:ctgov-nct02521181-2020-10-20`, retrieved 2026-10-26)
- Completion: 2018-06 (actual) (ClinicalTrials.gov record NCT02521181, source copy `cardio:ctgov-nct02521181-2020-10-20`, retrieved 2026-10-26)
- Results first posted: 2020-10-20 (ClinicalTrials.gov record NCT02521181, source copy `cardio:ctgov-nct02521181-2020-10-20`, retrieved 2026-10-26)
- Countries: United States (ClinicalTrials.gov record NCT02521181, source copy `cardio:ctgov-nct02521181-2020-10-20`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02521181-2020-10-20`, retrieved 2026-10-26)

## The registry's words

- Brief title: The BASE Study: Bicarbonate Administration to Stabilize Estimated Glomerular Filtration Rate (eGFR)
- Acronym: BASE
- Condition: Chronic Kidney Disease
- Intervention (Drug): Lower Dose Sodium Bicarbonate
- Intervention (Drug): Higher Dose Sodium Bicarbonate
- Intervention (Drug): Placebo
- Lead sponsor: Jennifer Gassman, PhD
- Lead sponsor class: OTHER
- Collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Collaborator class: NIH
- Collaborator: The Cleveland Clinic
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Chronic kidney disease (CKD) (`cardio:chronic-kidney-disease`)
- Registry lists this organization as a collaborator: National Institute of Diabetes and Digestive and Kidney Diseases (`cardio:niddk`)
- Registry lists this organization as a collaborator: The Cleveland Clinic (`cardio:org-the-cleveland-clinic`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: Oral Sodium Bicarbonate and Bone Turnover in CKD: A Secondary Analysis of the BASE Pilot Trial (`cardio:pubmed-38170601`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: c465ed8ed67b677ba6b77a33cfe08842faed6f19a20c2d9823b6fd5d53809357
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
